Thromboxane A2 mimetic (U-46619) induces hyperresponsiveness of smooth muscle in the canine bronchiole, but not in the trachea

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 54, Issue 2, 1996, Pages 129-134

  Takata, S ^a   Aizawa, H ^a   Shigyo, M ^a   Matsumoto, K ^a   Inoue, H ^a   Koto, H ^a   Hara, N ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ACETYLCHOLINE; RAMATROBAN; CARBAZOLE DERIVATIVE; DRUG DERIVATIVE; PROSTAGLANDIN ENDOPEROXIDE; SULFONAMIDE; THROMBOXANE A2; THROMBOXANE RECEPTOR; VASOCONSTRICTOR AGENT;

ANIMAL TISSUE; ARTICLE; BRONCHIOLE; BRONCHUS HYPERREACTIVITY; CONTROLLED STUDY; DOG; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE CONTRACTION; TRACHEA; ANIMAL; BRONCHUS; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; MALE; MUSCLE CONTRACTION; SMOOTH MUSCLE;

ANIMALIA; BRONCHUS; CANIS FAMILIARIS;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ACETYLCHOLINE; ANIMALS; BRONCHI; CARBAZOLES; DOGS; FEMALE; MALE; MUSCLE CONTRACTION; MUSCLE, SMOOTH; PROSTAGLANDIN ENDOPEROXIDES, SYNTHETIC; RECEPTORS, THROMBOXANE; SULFONAMIDES; THROMBOXANE A2; TRACHEA; VASOCONSTRICTOR AGENTS;

EID: 0029665810     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-3278(96)90070-8     Document Type: Article

References (38)

1. Svensson J., Strandberg K., Tuvemo T., Hamberg M. Effects on airway and vascular smooth muscle. Prostaglandins 1977; 14: 425.
2. Moncada S., Vane J. R. Pharmacology and endogenous role of prostaglandin endoperoxide, thromboxane A2 and prostacyclin. Pharmacol Rev 1979; 30: 293-331.
3. Aizawa H., Chung K. F., Leikauf G. D. et al. Significance of thromboxane generation in ozone-induced airway hyperresponsiveness in dogs. J Appl Physiol 1985; 59: 1918-1923.
4. Jones G. L., Saroea H. G., Watson R. M., O'Byrne P. M. Effect of an inhaled thromboxane mimetic (U-46619) on airway function in human subjects. Am Rev Respir Dis 1992; 145: 1270-1274.
5. Chung K. F., Evans T. W., Graf P. D., Nadel J. A. Modulation of cholinergic neurotransmission in canine airways by thromboxane mimetic U-46619. Eur J Pharmacol 1985; 117: 373-375.
6. Munoz N. M., Shioya T., Murphy T. M. et al. Potentiation of vagal contractile response by thromboxane mimetic U-46619. J Appl Physiol 1986; 61: 1173-1179.
7. Tamaoki J., Sekizawa K., Osborne M. L., Ueki I. F., Graf P. D., Nadel J. A. Platelet aggregation increases cholinergic neurotransmission in canine airway. J Appl Physiol 1987; 62: 2246-2251.
8. Barnes P. J. Muscarinic receptors in airways: recent developments. J Appl Physiol 1990; 68: 1777-1785.
9. 3-receptors mediate contraction of human central and peripheral airway smooth muscle. Pulmon Pharmacol 1990; 3: 47-52.
10. Hahn H. L., Willson A. G., Graf P. D., Fisher S. P., Nadel J. A. Interaction between serotonin and efferent vagus nerves in dog lungs. J Appl Physiol 1978; 44: 144-149.
11. 2α responsiveness in the dog. J Appl Physiol 1979; 47: 13-16.
12. Sheller J. R., Holtzman M. J., Skoogh B-E., Nadel J. A. Interaction of serotonin with vagal- and ACh-induced bronchoconstriction in canine lungs. J Appl Physiol 1982; 52: 964-966.
13. Cumming G. Airway morphology and its consequences. Bull Physiopathol Respir 1972; 8: 527-532.
14. Aizawa H., Inoue H., Miyazaki N., Ikeda T., Shigematsu N., Ito Y. Effects of azelastine on vagal neuroeffector transmission in canine and human airway. J Allergy Clin Immunol 1990; 86: 171-176.
15. Aizawa H., Miyazaki N., Inoue H., Ikeda T., Shigematsu N. Effect of endogenous tachykinins on neuroeffector transmission of vagal nerve in guinea-pig tracheal tissue. Respiration 1990; 57: 339-342.
16. Matsumoto K., Aizawa H., Inoue R. et al. Effects of epithelial cell supernatant on membrane potential and contraction of dog airway smooth muscles. Am J Respir Cell Mol Biol 1994; 10: 322-330.
17. Inoue T., Ito Y., Takeda K. Prostaglandin-induced inhibition of acetylcholine release from neuronal elements of dog tracheal tissue. J Physiol 1984; 349: 553-570.
18. 2 on excitatory neuroeffector transmission in the human bronchus. Prostaglandins 1990; 39: 639-655.
19. Walters E. H., O'Byrne P. M., Fabbri L. M., Graf P. D., Holtzman M. J., Nadel J. A. Control of neurotransmission by prostaglandins in canine trachealis smooth muscle. J Appl Physiol 1984; 57: 129-134.
20. Suzuki H., Morita K., Kuriyama H. Innervation and properties of the smooth muscle of the dog trachea. Jpn J Physiol 1976; 26: 303-320.
21. Russell J. A. Noradrenergic inhibitory innervation of canine airways. J Appl Physiol 1980; 48: 16-22.
22. Danser A. H. J., van den Ende R., Lorenz R. R., Flavahan N. A., Vanhoutte P. M. Prejunctional β1-adrenoceptors inhibit cholinergic transmission in canine bronchi. J Appl Physiol 1987; 62: 785-790.
23. Ito Y. Pre- and post-junctional actions of orocaterol, a β2-adrenoceptor stimulant, on dog tracheal tissue. Br J Pharmacol 1988; 95: 268-274.
24. Holtzman M. J., Sheller J. R., DiMeo M. Effect of ganglionic blockade on bronchial reactivity in atopic subjects. Am Rev Respir Dis 1980; 122: 17-25.
25. Small R. C., Foster R. W. Electrophysiological behavior of normal and sensitized airway smooth muscle. Am Rev Respir Dis 1987; 136: S7-S11.
26. Inoue T., Ito Y. Characteristics of neuro-effector transmission in the smooth muscle layer of dog bronchiole and modifications by autacoids. J Physiol 1986; 349: 553-570.
27. Xie Z., Hakoda H., Ito Y. Airway epithelial cells regulate membrane potential, neurotransmission and muscle tone of dog airway smooth muscle. J Physiol 1992; 449: 619-639.
28. Daniel E. E., Kannan M., Davis C., Posey-Daniel V. Ultrastractual studies on the neuromuscular control of human tracheal and bronchial muscle. Respir Physiol 1986; 63: 109-128.
29. Rosentreter U., Boshagen H., Seuter F., Perzborn E., Fiedler V. B. Synthesis and absolute configuration of the new thromboxane antagonist (3R)-3-(4-fluorophenylsulfonamido)-1,2,3,4-tetrahydro-9-carbazolepropanoic acid and comparison with its enantiomer. Arzneim-Forsch/Drug Res 1989; 39: 1519-1521.
30. 2 receptor antagonist on airway smooth muscle in vitro. Br J Pharmacol 1991; 104: 585-590.
31. Norel X., Labat C., Gardiner P. J., Brink C. Inhibitory effects of BAY u3405 n prostanoid-induced contractions in human isolated bronchial and pulmonary arterial muscle preparations. Br J Pharmacol 1991; 104: 591-595.
32. 2-induced bronchoconstriction in guinea-pig. Br J Pharmacol 1991; 104: 596-602.
33. Yanai M., Sekizawa K., Ohrui T., Sasaki H., Takishima T. Site of airway obstruction in pulmonary disease: direct measurement of intrabronchial pressure. J Appl Physiol 1992; 72: 1016-1023.
34. Wagner E. M., Liu M. C., Weinmann G. G., Permutt S., Bleecker E. R. Peripheral lung resistance in normal and asthmatic subjects. Am Rev Respir Dis 1990; 141: 584-588.
35. Chung K. F., Aizawa H., Becker A. B., Frick O., Gold W. M., Nadel J. A. Inhibition of antigen-induced airway hyperresponsiveness by a thromboxane synthetase inhibitor (OKY-046) in allergic dogs. Am Rev Respir Dis 1986; 134: 258-261.
36. 4 induced airway hyperresponsiveness in dogs. J Appl Physiol 1985; 59: 1941-1946.
37. Chung K. F., Aizawa H., Leikauf G. D., Ueki I. F., Evans T. W., Nadel J. A. Airway hyperresponsiveness induced by platelet activating factor: role of thromboxane generation. J Pharmacol Exp Ther 1986; 236: 580-584.
38. Beckett W S., Black C., Turner C., Spannhake E. W. M., Menkes H. A. In vivo exposure to ozone causes increased in vitro responses of small airways. Am Rev Respir Dis 1988; 137: 1236-1238.